tiprankstipranks
Baudax Bio (BXRXQ)
OTHER OTC:BXRXQ
US Market

Baudax Bio Income Statement

Last quarter (Q3 2023), Baudax Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Baudax Bio's net income was $-2.39M. See Baudax Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ -5.74M$ -1.36M$ -1.24M$ 206.00K$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 2.00M$ 2.58M$ 2.15M$ -480.00K$ ―
EBITDA
$ -33.58M$ -14.51M$ -72.19M$ -32.08M$ -64.64M
Operating Income
$ -56.81M$ -19.01M$ -74.79M$ -47.07M$ -65.04M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -58.80M$ -19.77M$ -76.10M$ -32.56M$ -73.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Baudax Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis